Table 1.
RET + PBO | RET + KET | No RET + KET | Total | Statistic | p | FDR α | |
---|---|---|---|---|---|---|---|
Age | 27.7 ± 8.33 | 26.5 ± 6.25 | 28.23 ± 9.57 | 27.48 ± 8.11 | 0.354 | 0.703 | 0.036 |
Gender (N F/M) | 9 | 11 | 15 | 35 | χ2(2) = 0.27 | 0.319 | 0.022 |
N smokers | 18 | 19 | 19 | 56 | χ2(2) = 0.095 | 0.954 | 0.047 |
AUDIT C | 9.1 ± 1.03 | 9.2 ± 1.03 | 8.9 ± 1.18 | 9.07 ± 1.08 | 0.596 | 0.553 | 0.028 |
AUDIT total | 22.17 ± 4.86 | 23.77 ± 5.15 | 20.47 ± 4.33 | 22.13 ± 4.93 | 3.559 | 0.033 | 0.003 |
SCID | 0.93 ± 0.83 | 1.1 ± 0.92 | 0.77 ± 0.57 | 0.93 ± 0.79 | 1.344 | 0.266 | 0.019 |
Motivation to reduce | 3.17 ± 0.59 | 3.13 ± 0.35 | 3.17 ± 0.38 | 3.16 ± 0.45 | 0.054 | 0.947 | 0.046 |
OCDS obsession | 6.6 ± 3.31 | 6.57 ± 3.38 | 5.53 ± 3.45 | 6.23 ± 3.38 | 0.966 | 0.385 | 0.024 |
OCDS compulsion | 11 ± 2.24 | 10.47 ± 2.66 | 10.93 ± 2.89 | 10.8 ± 2.59 | 0.371 | 0.691 | 0.033 |
OCDS total | 17.6 ± 5.13 | 17.03 ± 5.52 | 16.47 ± 5.91 | 17.03 ± 5.49 | 0.315 | 0.731 | 0.038 |
TLFB total units (last 14 days) | 135.2 ± 60.17 | 164.05 ± 86.82 | 130.04 ± 57.06 | 143.1 ± 70.16 | 2.098 | 0.129 | 0.008 |
TLFB daily units (last 14 days) | 9.74 ± 4.28 | 11.76 ± 6.22 | 9.29 ± 4.08 | 10.26 ± 5.01 | 2.11 | 0.127 | 0.006 |
TLFB total units (last 7 days) | 69.35 ± 32.21 | 86.73 ± 45.75 | 66.19 ± 32.08 | 74.09 ± 37.92 | 2.645 | 0.077 | 0.005 |
N drinking days (last 14 days) | 11.07 ± 2.72 | 11.07 ± 2.78 | 11.2 ± 2.44 | 11.11 ± 2.62 | 0.025 | 0.975 | 0.050 |
N drinking days (last 7 days) | 5.6 ± 1.33 | 5.63 ± 1.27 | 5.7 ± 1.47 | 5.64 ± 1.34 | 0.042 | 0.959 | 0.049 |
N binge days (last 14 days) | 3.3 ± 3.31 | 4.73 ± 3.65 | 2.83 ± 2.32 | 3.62 ± 3.21 | 2.974 | 0.056 | 0.004 |
N binge days (last 7 days) | 1.83 ± 1.79 | 2.6 ± 1.87 | 1.4 ± 1.35 | 1.94 ± 1.74 | 3.983 | 0.022 | 0.001 |
SOCRATES Recognition | 24.87 ± 3.14 | 23.83 ± 3.42 | 23.33 ± 4.21 | 24.01 ± 3.64 | 1.4 | 0.252 | 0.017 |
SOCRATES Ambivalence | 11.3 ± 2.9 | 10.97 ± 3.79 | 9.9 ± 3.45 | 10.72 ± 3.42 | 1.388 | 0.255 | 0.018 |
SOCRATES taking steps | 21.77 ± 4.04 | 21.33 ± 4.04 | 20.87 ± 4.52 | 21.32 ± 4.18 | 0.343 | 0.71 | 0.037 |
BAS drive | 11.1 ± 2.71 | 11.53 ± 2.98 | 10.57 ± 2.45 | 11.07 ± 2.72 | 0.951 | 0.39 | 0.027 |
BAS fun | 13.27 ± 2.75 | 14.33 ± 1.6 | 13.77 ± 1.72 | 13.79 ± 2.11 | 1.957 | 0.147 | 0.009 |
BAS reward | 16.63 ± 1.65 | 16.53 ± 2.62 | 16.3 ± 1.88 | 16.49 ± 2.07 | 0.201 | 0.819 | 0.041 |
BIS | 20.87 ± 2.69 | 19.57 ± 2.81 | 19.97 ± 2.57 | 20.13 ± 2.72 | 1.837 | 0.165 | 0.013 |
BDI | 15.47 ± 9.69 | 14.03 ± 8.58 | 11.3 ± 8.7 | 13.6 ± 9.07 | 1.657 | 0.197 | 0.014 |
CEOA sociability | 25.77 ± 3.43 | 26.3 ± 4.16 | 24.43 ± 3.82 | 25.5 ± 3.86 | 1.904 | 0.155 | 0.012 |
CEOA tension reduction | 7.3 ± 2.28 | 6.57 ± 1.81 | 7.03 ± 2.11 | 6.97 ± 2.07 | 0.96 | 0.387 | 0.026 |
CEOA liquid courage | 12.93 ± 2.48 | 12.63 ± 2.98 | 12.23 ± 3.08 | 12.6 ± 2.84 | 0.453 | 0.637 | 0.031 |
CEOA sexuality | 9.07 ± 2.8 | 8.3 ± 2.67 | 8.07 ± 2.43 | 8.48 ± 2.65 | 1.179 | 0.313 | 0.021 |
CEOA impairment | 20.97 ± 5.24 | 21.3 ± 5.49 | 20.7 ± 3.98 | 20.99 ± 4.9 | 0.111 | 0.895 | 0.044 |
CEOA Risk/aggression | 11.27 ± 3.04 | 12.03 ± 3.74 | 11.43 ± 3.46 | 11.58 ± 3.4 | 0.416 | 0.661 | 0.032 |
CEOA self perception | 7.17 ± 2.37 | 6.77 ± 2.92 | 6 ± 2.23 | 6.64 ± 2.54 | 1.657 | 0.197 | 0.015 |
DTS TOLERANCE | 2.92 ± 0.88 | 3.02 ± 1.01 | 2.93 ± 1.08 | 2.96 ± 0.98 | 0.091 | 0.913 | 0.045 |
DTS ABSORBANCE | 2.79 ± 1.08 | 3.01 ± 1.12 | 2.92 ± 1.31 | 2.91 ± 1.16 | 0.273 | 0.762 | 0.040 |
DTS APPRAISAL | 3.12 ± 0.96 | 3.55 ± 0.83 | 3.13 ± 1.09 | 3.27 ± 0.97 | 1.944 | 0.149 | 0.010 |
DTS REGULATION | 3.1 ± 1.02 | 2.7 ± 1.08 | 2.88 ± 1.02 | 2.89 ± 1.04 | 1.115 | 0.332 | 0.023 |
DTS TOTAL | 2.98 ± 0.81 | 3.07 ± 0.84 | 2.97 ± 0.98 | 3.01 ± 0.87 | 0.122 | 0.885 | 0.042 |
PANAS +VE | 32.07 ± 7.91 | 33.47 ± 7.25 | 31.93 ± 8.11 | 32.49 ± 7.71 | 0.359 | 0.699 | 0.035 |
PANAS −VE | 20.9 ± 6.38 | 21.1 ± 7.44 | 19.47 ± 6.91 | 20.49 ± 6.88 | 0.497 | 0.61 | 0.029 |
For continuous measures, the statistics given are mean ± SD, along with corresponding F values (DF 2, 87). For binary measures, Ns are given along with chi-square degrees of freedom and test values (denoted by χ2). “RET” = Retrieval, “KET” = Ketamine, “PBO” = Placebo. FDR α = False Discovery Rate alpha, calculated according to Benjamini and Hochberg36. P-values represent One-way ANOVA on group differences. Significant uncorrected p-values at p < 0.05 are highlighted in bold. Only p-values lower than the associated FDR α are significant at FDR- corrected p < 0.05. The groups did not differ on any baseline variables according to FDR criteria